-

Dexcom Announces Upcoming Conference Presentation

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026.

The live presentation is scheduled to begin at approximately 2:00 PM GMT (9:00 AM EST) and will be concurrently webcast.

Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference.

About DexCom, Inc.

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.

Category: IR

Contacts

DexCom, Inc.
Sean Christensen
Senior Vice President – Finance and Investor Relations
investor-relations@dexcom.com

DexCom, Inc.

NASDAQ:DXCM

Release Versions

Contacts

DexCom, Inc.
Sean Christensen
Senior Vice President – Finance and Investor Relations
investor-relations@dexcom.com

More News From DexCom, Inc.

Dexcom Marks Athenry Opening With Celebration of Commercial Production Milestone

ATHENRY, Ireland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in continuous glucose monitoring, today officially opened its state-of-the-art manufacturing facility in Athenry, County Galway, marking a major milestone in the company’s investment in Ireland and its manufacturing presence in Europe, the Middle East and Africa. The official opening ceremony, attended by Minister for Public Expenditure, Infrastructure, Public Service Reform and Digitalisation, Jack Chambers, TD; Mi...

Dexcom Invites the Global Diabetes Community to Share Their Stories Through A Letter to Diabetes Campaign

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today launched A Letter to Diabetes in honor of National Diabetes Awareness Month and World Diabetes Day, creating a platform for people around the world to put into words everything they’ve wanted to say about their diabetes journey, from the heartfelt and humorous to the hopeful and unexpected.Throughout November, anyone touched by diabetes is invited to share their own letter to diabetes, includi...

Dexcom Reports Third Quarter 2026 Financial Results

SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports Third Quarter 2026 Financial Results...
Back to Newsroom